trending Market Intelligence /marketintelligence/en/news-insights/trending/MAr22mitf_Mgtr5jKjq8SA2 content esgSubNav
In This List

ContraVir Pharmaceuticals gets Nasdaq noncompliance notice

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


ContraVir Pharmaceuticals gets Nasdaq noncompliance notice

ContraVir Pharmaceuticals Inc. said it was evaluating its options after its stocks fell out of compliance with Nasdaq's minimum bid listing requirement of $1 per share.

The company has until Dec. 4 to regain compliance and may be eligible for a further extension.

The notice has no immediate effect on the company's listing on the stock market.